Trends of cervical cancer mortality in the member states of the European Union

European Journal of Cancer

Volumn 45, Issue 15, 2009, Pages 2640-2648

  Arbyn, Marc ^a   Raifu, Amidu O ^a   Weiderpass, Elisabete ^b,c,d,e   Bray, Freddie ^b,f   Anttila, Ahti ^g  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b CANCER REGISTRY OF NORWAY   (Norway)

^c FOLKHÄLSAN RESEARCH CENTER   (Finland)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF TROMSØ   (Norway)

^f UNIVERSITY OF OSLO   (Norway)

^g FINNISH CANCER REGISTRY   (Finland)

Author keywords

Cervical cancer; Europe; European Union; Mortality; Trend analysis

Indexed keywords

ARTICLE; BULGARIA; CANCER MORTALITY; CANCER SCREENING; CAUSE OF DEATH; CONTROLLED STUDY; CZECH REPUBLIC; ESTONIA; EUROPEAN UNION; FEMALE; FINLAND; FRANCE; GROUPS BY AGE; HUMAN; LATVIA; LITHUANIA; MAJOR CLINICAL STUDY; POLAND; PRIORITY JOURNAL; ROMANIA; SLOVAKIA; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; EUROPE; EUROPEAN UNION; FEMALE; HUMANS; MIDDLE AGED; MORTALITY; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 70349185355     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.07.018     Document Type: Article

References (42)

1. Arbyn M., Autier P., and Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol 18 (2007) 1425-1427
2. IARC Monograph Working Group zur Hausen H, Arbyn M, Villa L, et al. IARC Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses, vol. 90. Lyon: IARC Press; 2007.
3. IARC. Cervix cancer screening. IARC Handbooks of Cancer Prevention, vol. 10. Lyon: IARC Press; 2005.
4. Laara E., Day N.E., and Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1 (1987) 1247-1249
5. Bray F., Loos A.H., McCarron P., et al. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening. Cancer Epidemiol Biomarkers Prev 14 (2005) 677-686
6. Arbyn M., Van Oyen H., Sartor F., Tibaldi F., and Molenberghs G. Description of the influence of age, period and cohort effects on cervical cancer mortality by loglinear Poisson models (Belgium, 1955-94). Arch Public Health 60 (2002) 73-100
7. Karim-Kos H.E., de Vries E., Soerjomataram I., Lemmens V., Siesling S., and Coebergh J.W. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 (2008) 1345-1389
8. Adami H.-.O., Ponten J., Sparen P., and Bergstrom R. Survival trend after invasive cervical cancer diagnosis in sweden before and after cytologic screening. 1960-1984. Cancer 73 (1994) 140-147
9. Anttila A., and Laara E. Cervix cancer: geographical correlations. In: Sankila R., Demaret E., Hakama M., Lynge E., Schouten L.J., and Parkin D.M. (Eds). Evaluation and monitoring of screening programmes (2000), Europe against Cancer Programme, Brussels, Luxemburg
10. Arbyn M., and Geys H. Trend of cervical cancer mortality in Belgium (1954-94): tentative solution for the certification problem of not specified uterine cancer. Int J Cancer 102 (2002) 649-654
11. Loos A.H., Bray F., McCarron P., Weiderpass E., Hakama M., and Parkin D.M. Sheep and goats: separating cervix and corpus uteri from imprecisely coded uterine cancer deaths, for studies of geographical and temporal variations in mortality. Eur J Cancer 40 (2004) 2794-2803
12. Levi F., Lucchini F., Negri E., Franceschi S., and La Vecchia C. Cervical cancer mortality among young women in Europe: patterns and trends. Eur J Cancer 36 (2000) 2266-2271
13. Jenssen O.M., Estève J., Moller H., and Renard H. Cancer in the European Community and its member states. Eur J Cancer 26 (1990) 1167-1256
14. Goldstein R. Sed10: Patterns of missing data. Stata Technical Bulletin 32 (1996) 12-13
15. Little R.J.A., and Rubin D.B. Statistical analysis with missing data. 2nd ed. (2002), Wiley, New York
16. Durrant GB. Imputation methods for handling item-nonresponse in the social sciences: a methodological review. University of Southampton, ESRC National Centre for Research Methods and Southampton Statistical Sciences Research Institute (S3RI), 2005.
17. Arbyn M., and Raifu A.O. Trends of cervical cancer mortality in Europe (2009), Scientific Institute of Public Health, Brussels IPH [Report Epidemiology No.:07]
18. Waterhouse J.A.H., Muir C.S., and Shanmugaratnam K. Cancer incidence in five continents. 4th ed. (1976), International Agency for Research on Cancer, Lyon
19. Software produced by the Statistical Research and Application Branch, National Cancer Institute [computer program]. Silver Spring, US, 2008.
20. Lerman P.M. Fitting segmented regression models by grid search. Appl Stat 29 (1980) 77-84
21. Kim H.-.J., Fay M.P., Feuer E.J., and Midthune D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19 (2000) 335-351
22. Devesa S.S., Donaldson J., and Fears T. Graphical presentation of trends in rates. Am J Epidemiol 141 (1995) 300-304
23. Beral V. Cancer of the cervix: a sexually transmitted infection?. Lancet 25 (1974) 1037-1040
24. Osmond C., and Gardner M.J. Age, period and cohort models applied to cancer mortality rates. Stat Med 1 (1982) 245-259
25. Arbyn M., Raifu A.O., Autier P., and Ferlay J. Burden of cervical cancer in Europe: estimates for 2004. Ann Oncol 18 (2007) 1708-1715
26. Llorca J., Prieto M.D., and Delgado-Rodr¡guez M. Increase in cervical cancer mortality in Spain, 1951-1991. J Epidemiol Community Health 53 (1999) 408-411
27. Bosch F.X. Trends in cervical cancer mortality. J Epidemiol Community Health 53 (1999) 392
28. Llorca J., Rodriguez-Cundin P., Dierssen-Sotos T., and Prieto-Salceda D. Cervical cancer mortality is increasing in Spanish women younger than 50. Cancer Letters 240 (2006) 36-40
29. Zakelj M.P., Kirn V.P., Skrlec F., and Selb J. Can we rely on cancer mortality data? Checking the validity of cervical cancer mortality data for Slovenia. Radiol Oncol 35 (2002) 243-247
30. Suzan F., Séblain C., Boussac-Rarebska M., et al. Survey on the distribution of "uterus cancer, cervix corpus cancer and not otherwise specified cancer" among death certificates for cervix cancer and corpus uteri cancer, France. Bull Epidémiol Hebdom 9-10 (2007) 79-81
31. Capocaccia R., Martina L., Inghelmann R., et al. A method to estimate mortality trends when death certificates are imprecisely coded: an application to cervical cancer in Italy. Int J Cancer 124 (2009) 1200-1205
32. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer 37 (2001) 4-66
33. Laukkanen P., Koskela P., Pukkala E., et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 84 (2003) 2105-2109
34. Lehtinen M., Kaasila M., Pasanen K., et al. Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s. Int J Cancer 119 (2006) 2612-2619
35. De Vuyst H., Clifford G., Li N., and Franceschi S. HPV infection in Europe. Eur J Cancer 45 15 (2009) 2632-2639
36. Arbyn M., Rebolj M., de Kok I.M., Becker N., O'Reilly M., and Andrae B. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 45 15 (2009) 2671-2678
37. Giard R.W.M., Coebergh J.W.W., and Wijnen J.A. Causes of low effectiveness of population screening for cervival cancer. Ned Tijdschr Geneeskd 141 (1996) 317-321
38. Raffle A.E. Deaths from cervical cancer began falling before screening programmes were established. BMJ 315 (1997) 953-954
39. Anttila A., and Nieminen P. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods. Coll Antropol 31 Suppl. 2 (2007) 17-22
40. Hristova L., and Hakama M. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017. Acta Oncol 36 Suppl. 9 (1997) 1-60
41. Bielska-Lasota M., Inghelmann R., Poll-Franse L., and Capocaccia R. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study. Gynecol Oncol 105 (2007) 609-619
42. Ronco G., and Anttila A. Chapter 7: Summary table of key performance indicators. In: Arbyn M., Anttila A., Jordan J., et al. (Eds). European guidelines for quality assurance in cervical cancer screening. 2nd ed. (2008), Office for Official Publications of the European Communities, Luxembourg 231-242